Bengaluru-based Anthem Biosciences, a Contract Research, Development and Manufacturing Organisation (CRDMO) firm, is launching its ₹3,395 crore IPO from July 14 to July 16. The issue, entirely an Offer for Sale, has a price band of ₹540 to ₹570 per share. The company reported ₹1,844 crore revenue and ₹451 crore net profit in FY25.